-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Medtronic, Raises Price Target to $116

Benzinga·01/08/2026 21:16:27
Listen to the news
Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $111 to $116.